This site is intended for Healthcare professionals only.

9 more formulations including Methylprednisolone Inj under Price Ceiling: NPPA order


9 more formulations including Methylprednisolone Inj under Price Ceiling: NPPA order

New Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India has fixed the ceiling prices of 09 formulations under the Drugs (Prices Control) Order, 2013 exclusive of goods and services tax (GST).

The notice states that in the exercise of the powers conferred by paragraphs 4, 6, 10, 11, 14, 16, 17 and 18 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May 2013 and S.O. 701(E) dated 10th March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order(s) of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) specified in the Column (7) of the table regarding formulation specified in mentioned in the table in so far as it relates to formulation pack mentioned in the table below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes/revises the price as specified in column (5) of the table herein below as ceiling price exclusive of goods and services tax applicable, if any, in respect of the Scheduled formulation(s) specified in the corresponding entry in column (2) of the said Table with the dosage form & strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof:

Following are the details

Sl.No Name of the
Scheduled
Formulation
Dosage form &
Strength
Unit Ceiling
Price (Rs.)
Review Order
number and
date
Existing SO number
and date
(1) (2) (3) (4) (5) (6) (7)
1. Clomiphene Tablet 50mg 1 Tablet 7.56 31015/36/2017-
Pricing dated
24.8.2017
2058(E) dated 30.6.2017
(at Sl. No. 146)
2. Clomiphene Tablet 100mg 1 Tablet 11.08 31015/36/2017-
Pricing dated
24.8.2017
2058(E) dated 30.6.2017
(at Sl. No. 147)
3. Adenosine Injection 3mg/ml 1 ML 89.34 31015/12/2017-
Pricing dated
28.9.2017 &
31015/39/2017-
Pricing dated
24.8.2017
2058(E) dated 30.6.2017
(at Sl. No. 15)
4. Povidone Iodine Solution 10% 1 ML 0.76 31015/34/2017-
Pricing dated
28.9.2017 & 31015/20/2017-Pricing dated 28.9.2017
2058(E) dated 30.6.2017
(at Sl. No. 490)
5. Methylprednisolone Injection 40mg/ml 1 ML 48.97 31015/26/2017-
Pricing dated
30.10.2017
2400(E) dated 28.7.2017
(at Sl. No. 23)
6. Sodium Valproate CR Tablets 300mg 1
Tablet
5.71 31015/68/2017-Pricing dated
28.11.2017 & 31015/69/2017-Pricing dated
28.11.2017
2058(E) dated 30.6.2017
(at Sl. No. 556)
7. Sodium Valproate CR Tablets 500mg 1
Tablet
8.85 31015/68/2017-Pricing dated
28.11.2017 &
31015/69/2017-Pricing dated
28.11.2017
2058(E) dated 30.6.2017
(at Sl. No. 555)
8. Isosorbide 5
Mononitrate
Tablet 20 mg 1
Tablet
2.98 31015/31/2017-
Pricing dated
28.11.2017 &
31015/39/2017-
Pricing dated
24.08.2017
2058(E) dated 30.6.2017
(at Sl. No. 314)
9. Lignocaine Topical Forms 2-
5%
1 gm or
1 ml
0.98 31015/44/2017-
Pricing dated
28.11.2017
2058(E) dated 30.6.2017
(at Sl. No. 354)

The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of production/import and sale of scheduled formulations in Form – III of Schedule – II of the DPCO, 2013 through IPDMS.

Any manufacturer intending to discontinue production of said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and/or import of scheduled formulation in Form -IV of Schedule – II of the DPCO, 2013 at least six months prior to the intended date of discontinuation.

The manufacturers not complying with the ceiling price and notes specified shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955.

Consequent to the issue of ceiling prices of such formulations as specified, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.

Below is the attachment for the same.

http://www.nppaindia.nic.in/ceiling/press13feb18/Formulation_Prices(09).pdf

Medical Dialogues had earlier reported that NPPA had fixed the retail Prices of 30 formulations under DPCO 2013 exclusive of goods and services tax (GST).

Read also: NPPA fixes retail prices of 30 formulations, including Insulin, Metoprolol ER; check out details



Source: self
0 comment(s) on 9 more formulations including Methylprednisolone Inj under Price Ceiling: NPPA order

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted